Optimization of CTCs and THCs Isolation From Human Blood Based on Genesis Technology as a Strategy of Urothelial Carcinoma Monitoring
Saved in:
| Main Authors: | I. Arévalo, L. García, I. Lodewijk, E. Montesinos, O. Alberquilla, R. Sánchez, D. Castellanos, J. Paramio, M. Dueñas, C. Rubio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-11-01
|
| Series: | The Journal of Liquid Biopsy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950195423000784 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquid Biopsy Characterization of CTCs and THCs Isolated in Patients with UC
by: C. Rubio, et al.
Published: (2023-11-01) -
TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
by: Qingyu Liao, et al.
Published: (2024-03-01) -
Urothelial Carcinoma of the Bladder Metastatic to Bone Marrow Presenting as Isolated Thrombocytopenia
by: Robert C. Chan, et al.
Published: (2007-01-01) -
Enhanced Blood Sampling for Ultra-sensitive Detection of ctDNA and CTCs in Neoadjuvant-treated Early Breast Cancer Patients
by: A. Alba-Bernal, et al.
Published: (2023-11-01) -
Nested Variant of Urothelial Carcinoma
by: Anthony Kodzo-Grey Venyo
Published: (2014-01-01)